ADRB1 anticorps (Internal Region)
-
- Antigène Voir toutes ADRB1 Anticorps
- ADRB1 (Adrenergic, beta-1-, Receptor (ADRB1))
-
Épitope
- Internal Region
-
Reactivité
- Humain
-
Hôte
- Chèvre
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp ADRB1 est non-conjugé
-
Application
- ELISA, Immunohistochemistry (IHC), Immunofluorescence (IF)
- Fonction
- ADRB1
- Séquence
- ESDEARRCYN DPK
- Réactivité croisée
- Chien, Humain, Souris, Rat
- Purification
- Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
- Classe de qualité
- Verified
- Immunogène
- Peptide with sequence ESDEARRCYNDPK, from the internal region of the protein sequence according to NP_000675.1.
- Isotype
- IgG
-
-
- Indications d'application
-
Immunohistochemistry: Paraffin embedded Human Heart. Recommended concentration: 6 μg/mL.
Western Blot: This antibody is not recommended for use in Western blotting.
Peptide ELISA: antibody detection limit dilution 1:2000.
- Commentaires
-
Immunofluorescence: Strong expression of the protein seen in the plama membrane and cytoplasm of HeLa cells. Recommended concentration: 10μg/ml.
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 0.5 mg/mL
- Buffer
- Supplied at 0.5 mg/mL in Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin.
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Conseil sur la manipulation
- Minimize freezing and thawing.
- Stock
- -20 °C
- Stockage commentaire
- Aliquot and store at -20°C, with minimal freeze/thawing. A working aliquot may be refrigerated at 4°C for a few weeks and still remain viable.
-
-
Difference between beta1-adrenoceptor autoantibodies of human and animal origin-Limitations detecting beta1-adrenoceptor autoantibodies using peptide based ELISA technology." dans: PLoS ONE, Vol. 13, Issue 2, pp. e0192615, (2018) (PubMed).
: "Functional autoantibodies in patients with different forms of dementia." dans: PLoS ONE, Vol. 13, Issue 3, pp. e0192778, (2018) (PubMed).
: "Performance and in-house validation of a bioassay for the determination of beta1-autoantibodies found in patients with cardiomyopathy." dans: Heliyon, Vol. 3, Issue 7, pp. e00362, (2017) (PubMed).
: "The first aptamer-apheresis column specifically for clearing blood of ?1-receptor autoantibodies." dans: Circulation journal : official journal of the Japanese Circulation Society, Vol. 76, Issue 10, pp. 2449-55, (2012) (PubMed).
: "Aptamer neutralization of beta1-adrenoceptor autoantibodies isolated from patients with cardiomyopathies." dans: Circulation research, Vol. 109, Issue 9, pp. 986-92, (2011) (PubMed).
: "Distinct patterns of autoantibodies against G-protein-coupled receptors in Chagas' cardiomyopathy and megacolon. Their potential impact for early risk assessment in asymptomatic Chagas' patients." dans: Journal of the American College of Cardiology, Vol. 55, Issue 5, pp. 463-8, (2010) (PubMed).
: "
-
Difference between beta1-adrenoceptor autoantibodies of human and animal origin-Limitations detecting beta1-adrenoceptor autoantibodies using peptide based ELISA technology." dans: PLoS ONE, Vol. 13, Issue 2, pp. e0192615, (2018) (PubMed).
-
- Antigène
- ADRB1 (Adrenergic, beta-1-, Receptor (ADRB1))
- Autre désignation
- ADRB1 (ADRB1 Produits)
- Synonymes
- anticorps ADRB1R, anticorps B1AR, anticorps BETA1AR, anticorps RHR, anticorps RATB1AR, anticorps X-Beta1AR, anticorps BAR1, anticorps zgc:194728, anticorps zgc:194731, anticorps ADRB1, anticorps Adrb-1, anticorps beta-AR, anticorps adrenoceptor beta 1, anticorps adrenoceptor beta 1 L homeolog, anticorps adrenergic, beta-1-, receptor, anticorps adrenergic receptor, beta 1, anticorps ADRB1, anticorps Adrb1, anticorps adrb1.L, anticorps adrb1
- Sujet
- ADRB1, adrenergic, beta-1-, receptor, ADRB1R, B1AR, BETA1AR, RHR, beta-1-adrenergic receptor
- Poids moléculaire
- 51.2kDa
- ID gène
- 153
- NCBI Accession
- NP_000675
- Pathways
- cAMP Metabolic Process, Cellular Glucan Metabolic Process, Regulation of Muscle Cell Differentiation, Synaptic Membrane, Regulation of G-Protein Coupled Receptor Protein Signaling, G-protein mediated Events, Interaction of EGFR with phospholipase C-gamma, Brown Fat Cell Differentiation
-